Biochemical and Immunological Properties of a Viral Hybrid Particle Expressing the Plasmodium vivax Merozoite Surface Protein 1 C-terminal Region

Molecular Medicine

Volumn 6, Issue 3, 2000, Pages 238-245

  Wunderlich, Gerhard ^a   del Portillo, Hernando A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Enzyme linked Immuno Sorbent Assay (ELISA); Future Vaccine Trials; Hybrid Particle; Merozoite Surface Protein; Plasmodium Vivax Merozoite Surface Protein

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HYBRID PROTEIN; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; PARASITE ANTIGEN; PRIMER DNA; PROTOZOAL PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL STRAIN COS1; CHEMISTRY; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; IMMUNOLOGY; MOUSE; NUCLEOTIDE SEQUENCE; PLASMODIUM VIVAX;

ANIMALS; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; BASE SEQUENCE; COS CELLS; DNA PRIMERS; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PLASMODIUM VIVAX; PROTOZOAN PROTEINS; RECOMBINANT FUSION PROTEINS;

MLCS; MLOWN;

EID: 0034151431     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.1007/BF03402116     Document Type: Review

References (26)

1. L.H. Miller M.F. Good D.C. Kaslow Vaccines against the blood stages of falciparum malaria Adv. Exp. Med. Biol. 1998 452 193 205 10.1007/978-1-4615-5355-7_22 1:CAS:528:DyaK1cXotVGqsb8%3D
2. S.P. Chang S.E. Case W.L. Gosnell et al. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria Infect. Immun. 1996 64 253 261 8557348 173753 1:CAS:528:DyaK28Xhtlymsg%3D%3D
3. C.F. Yang W.E. Collins J.S. Sullivan D.C. Kaslow L.H. Xiao A.A. Lal Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant Infect. Immun. 1999 67 342 349 9864235 96316 1:CAS:528:DyaK1MXisFSmsA%3D%3D
4. K.L. Perera S.M. Handunnetti I. Holm S. Longacre K. Mendis Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria Infect. Immun. 1998 66 1500 1506 9529073 108080 1:CAS:528:DyaK1cXitFCisLc%3D
5. T.M. Daly C.A. Long A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice Infect. Immun. 1993 61 2462 2467 8363656 280869 1:CAS:528:DyaK3sXlsFOrsLo%3D
6. W.A. Keitel K.E. Kester K.E. Atmar et al. Phase 1 trial of two recombinant vaccines containing the 19 kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (MSP1(19)) and T helper cell epitopes of tetanus toxoid Vaccine 1999 18 531 539 10.1016/S0264-410X(99)00221-2 1:CAS:528:DyaK1MXnslGgt70%3D
7. J.M. Burns Jr. W.R. Majarian J.F. Young T.M. Daly C.A. Long A protective monoclonal antibody recognizes an epitope in the carboxylterminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii. J. Immunol. 1989 143 2670 2676 2477452 1:CAS:528:DyaK3cXhvFKmug%3D%3D
8. P.A. Burghaus B.T. Wellde T. Hall et al. Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection Infect. Immun. 1996 64 3614 3619 8751907 174271 1:CAS:528:DyaK28XltlKhsb4%3D
9. M.A. Herrera F. Rosero S. Herrera et al. Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection Infect. Immun. 1992 60 154 158 1370271 257516 1:CAS:528:DyaK38XotFKqug%3D%3D
10. S.P. Chang C.M. Nikaido A.C. Hashimoto C.Q. Hashiro B.T. Yokota G.S. Hui Regulation of antibody specificity to Plasmodium falciparum merozoite surface protein-1 by adjuvant and MHC haplotype J. Immunol. 1994 152 3483 3490 8144929 1:CAS:528:DyaK2cXis1Oks7k%3D
11. T.M. Daly C.A. Long Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection Infect. Immun. 1996 64 2602 2608 8698485 174116 1:CAS:528:DyaK28XjvFWquro%3D
12. J.L. Greenstein V.C. Schad W.H. Goodwin et al. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120 J. Immunol. 1992 148 3970 3977 1376346 1:CAS:528:DyaK38XltV2ltrc%3D
13. F. Delpeyroux N. Chenciner A. Lim M. Lambert M. Malpiece R.E. Streeck Insertions in the hepatitis B surface antigen: Effect on assembly and secretion of the 22 nm-particles from mammalian cells J. Mol. Biol. 1987 195 343 350 10.1016/0022-2836(87)90655-3 1:CAS:528:DyaL2sXksFehurc%3D
14. S.M. LeBorgne M. LeGrand M. Schleef et al. In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen Virology 1998 240 304 315 10.1006/viro.1997.8942 1:CAS:528:DyaK1cXmtFCiug%3D%3D
15. A.F. von Brunn K. Früh H.-M. Müller H.W. Zentgraf H. Bujard Epitopes of the human malaria parasite P. falciparum carried on the surface of HBsAg particles elicit an immune response against the parasite Vaccine 1991 9 477 483 10.1016/0264-410X(91)90032-2
16. J.A. Stoute M. Slaoui D.G. Heppner et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria N. Engl. J. Med. 1997 336 86 91 10.1056/NEJM199701093360202 1:STN:280:DyaK2s7jtVSlsQ%3D%3D
17. D.M. Gordon T.W. McGovern U. Krzych et al. Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine J. Infect. Dis. 1996 171 1576 1586 10.1093/infdis/171.6.1576
18. C.I. de Oliveira G. Wunderlich G. Levitus et al. Antigenic properties of the merozoite surface protein 1 gene of Plasmodium vivax. Vaccine 1999 17 2959 2568 10.1016/S0264-410X(99)00176-0
19. P. Valenzuela L. Rall M. Zaldivar M. Quiroga P. Gray W. Rutter The nucleotide sequence of the hepatitis B virus viral genome and the identification of the major viral genes ICNUCLA Symp. Mol. Cell Biol. 1980 18 57 70 1:CAS:528:DyaL3MXhvVOjur4%3D
20. V. Bruss R. Thomssen Mapping a region of the large envelope protein required for hepatitis B virion maturation J. Virol. 1994 68 1643 1650 8107225 236622 1:CAS:528:DyaK2cXitl2ktLY%3D
21. G. Levitus F. Mertens M.A. Sperança L.M. Camargo M.U. Ferreira H.A. del Portillo Characterization of naturally acquired human IgG responses against the N-terminal region of the merozoite surface protein 1 of Plasmodium vivax Am. J. Trop. Med. Hyg. 1994 51 68 76 10.4269/ajtmh.1994.51.68 1:CAS:528:DyaK2cXmslyns7g%3D
22. K.H. Heermann U. Goldmann W. Schwartz T. Seyffarth H. Baumgarten W.H. Gerlich Large surface proteins of hepatitis B virus containing the pre-s sequence J. Virol. 1984 52 396 402 6492255 254539 1:CAS:528:DyaL2cXmt1Kntr4%3D
23. I.S. Soares G. Levitus J.M. Souza H.A. del Portillo M.M. Rodrigues Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria Infect. Immun. 1997 65 1606 1614 9125537 175182 1:CAS:528:DyaK2sXjtVKqt78%3D
24. S. Vreden J. Verhave T. Oettinger R. Sauerwein J. Meuwissen Phase I clinical trial of a recombinant malaria vaccine consisting of the circumsporozoite repeat region of Plasmodium falciparum coupled to hepatitis B surface antigen Am. J. Trop. Med. Hyg. 1991 45 533 538 10.4269/ajtmh.1991.45.533 1:STN:280:DyaK38%2FlvFKktg%3D%3D
25. T.M. Daly C.A. Long Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria J. Immunol. 1995 155 236 243 7602100 1:CAS:528:DyaK2MXmsFKht7o%3D
26. I.S. Soares J.W. Barnwell M.U. Ferreira et al. A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies Mol. Med. 1999 5 459 470 10449807 2230447 1:CAS:528:DyaK1MXlvFWjtrg%3D